456 related articles for article (PubMed ID: 17397824)
1. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase inhibition reverses vascular dysfunction after gamma-irradiation.
Beller CJ; Radovits T; Seres L; Kosse J; Krempien R; Gross ML; Penzel R; Berger I; Huber PE; Hagl S; Szabó C; Szabó G
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1528-35. PubMed ID: 16863929
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation.
Tasatargil A; Tekcan M; Celik-Ozenci C; Ece Gungor N; Dalkiran B
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):127-37. PubMed ID: 19713411
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta.
Korkmaz S; Radovits T; Barnucz E; Neugebauer P; Arif R; Hirschberg K; Loganathan S; Seidel B; Karck M; Szabó G
Eur J Pharmacol; 2009 Aug; 615(1-3):155-62. PubMed ID: 19482016
[TBL] [Abstract][Full Text] [Related]
6. [Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing].
Radovits T
Orv Hetil; 2008 Dec; 149(50):2377-85. PubMed ID: 19073445
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.
Xiao CY; Chen M; Zsengellér Z; Li H; Kiss L; Kollai M; Szabó C
J Pharmacol Exp Ther; 2005 Mar; 312(3):891-8. PubMed ID: 15523000
[TBL] [Abstract][Full Text] [Related]
8. Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil.
Radovits T; Arif R; Bömicke T; Korkmaz S; Barnucz E; Karck M; Merkely B; Szabó G
Eur J Pharmacol; 2013 Jun; 710(1-3):110-9. PubMed ID: 23623933
[TBL] [Abstract][Full Text] [Related]
9. Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging.
Pacher P; Mabley JG; Soriano FG; Liaudet L; Szabó C
Int J Mol Med; 2002 Jun; 9(6):659-64. PubMed ID: 12011985
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation.
Szabó G; Soós P; Heger U; Flechtenmacher C; Bährle S; Zsengellér Z; Szabó C; Hagl S
Eur J Cardiothorac Surg; 2005 Feb; 27(2):226-34. PubMed ID: 15691675
[TBL] [Abstract][Full Text] [Related]
11. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase.
Benkö R; Pacher P; Vaslin A; Kollai M; Szabó C
Life Sci; 2004 Jul; 75(10):1255-61. PubMed ID: 15219813
[TBL] [Abstract][Full Text] [Related]
12. Role of peroxynitrite and activation of poly (ADP-ribose) synthase in the vascular failure induced by zymosan-activated plasma.
Cuzzocrea S; Zingarelli B; O'Connor M; Salzman AL; Caputi AP; Szabó C
Br J Pharmacol; 1997 Oct; 122(3):493-503. PubMed ID: 9351506
[TBL] [Abstract][Full Text] [Related]
13. The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction.
Radovits T; Seres L; Gero D; Lin LN; Beller CJ; Chen SH; Zotkina J; Berger I; Groves JT; Szabó C; Szabó G
Mech Ageing Dev; 2007 Feb; 128(2):173-81. PubMed ID: 17116320
[TBL] [Abstract][Full Text] [Related]
14. The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia.
Abdallah Y; Gligorievski D; Kasseckert SA; Dieterich L; Schäfer M; Kuhlmann CR; Noll T; Sauer H; Piper HM; Schäfer C
Cardiovasc Res; 2007 Feb; 73(3):568-74. PubMed ID: 17196568
[TBL] [Abstract][Full Text] [Related]
15. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta rapidly inhibits aortic endothelium-dependent relaxation by a DNA transcription-dependent mechanism.
Loughrey JP; Laffey JG; Moore BJ; Lynch F; Boylan JF; McLoughlin P
Crit Care Med; 2003 Mar; 31(3):910-5. PubMed ID: 12627004
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase inhibition in oxidant-stressed endothelial cells prevents oncosis and permits caspase activation and apoptosis.
Walisser JA; Thies RL
Exp Cell Res; 1999 Sep; 251(2):401-13. PubMed ID: 10471325
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta.
Tasatargil A; Dalaklioglu S; Sadan G
Pharmacology; 2004 Oct; 72(2):99-105. PubMed ID: 15331915
[TBL] [Abstract][Full Text] [Related]
19. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.
Garcia Soriano F ; Virág L; Jagtap P; Szabó E; Mabley JG; Liaudet L; Marton A; Hoyt DG; Murthy KG; Salzman AL; Southan GJ; Szabó C
Nat Med; 2001 Jan; 7(1):108-13. PubMed ID: 11135624
[TBL] [Abstract][Full Text] [Related]
20. Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.
Radovits T; Seres L; Gero D; Berger I; Szabó C; Karck M; Szabó G
Exp Gerontol; 2007 Jul; 42(7):676-85. PubMed ID: 17383839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
